Abstract
Sentinel lymph node biopsy (SLNB) is the gold standard for the evaluation of axilla in clinically node-negative early breast cancers. There is limited data on the role and efficacy of the same in the post lumpectomy scenario. This prospective interventional study was conducted over 1 year on 30 post lumpectomy pT1/2 cN0 patients. SLNB was performed by preoperative lymphoscintigram using technetium-labeled human serum albumin followed by intraoperative blue dye injection. Sentinel nodes were identified based on blue dye uptake and gamma probe and sent for intra operative frozen section. Completion axillary nodal dissection was performed in all cases. The primary end point was sentinel node identification rate and accuracy of nodal frozen section. Sentinel node identification rate was 86.7% (n = 26/30) for scintigraphy alone and 96.7% (n = 29/30) using combined method. Average sentinel nodal yield/patient was 3.6 (range 0–7). Maximum yield was seen for hot and blue nodes (1.86). Sensitivity (n = 9/9) and specificity (n = 19/19) of frozen section were 100% with a false negative rate of 0% (0/19). Demographic factors such as age, body mass index, laterality, quadrant, biology, grade, and pathological T stage had no impact on the identification rate. Sentinel lymph node using dual tracer has a high identification rate and a low false negative rate post lumpectomy. Age, body mass index, laterality, quadrant, grade, biology, and pathological T size had no impact on the identification rate.
Similar content being viewed by others
References
Ghossain A, Ghossain MA (2009) History of mastectomy before and after Halsted. J Med Liban 57(2):65–71
Bhargavan RV, Mirza A, Cherian K, Krishna J, Augustine P (2020) Level III dissection in locally advanced breast cancer following neoadjuvant chemotherapy: a retrospective study. Ann R Coll Surg Engl 102(3):214–219. https://doi.org/10.1308/rcsann.2019.0142
Lanng C, Hoffmann J, Galatius H, Engel U (2007) Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer. Eur J Surg Oncol 33(3):281–284. https://doi.org/10.1016/j.ejso.2006.09.032
Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, Benson AB 3rd, Bosserman LD, Burstein HJ, Cody H 3rd, Hayman J, Perkins CL, Podoloff DA, Giuliano AE, American Society of Clinical Oncology Clinical Practice (2014) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 32(13):1365–1383. https://doi.org/10.1200/JCO.2013.54.1177
Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HMC, Wolmark N (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–933. https://doi.org/10.1016/S1470-2045(10)70207-2
Cardoso F, Cataliotti L, Costa A, Knox S, Marotti L, Rutgers E, Beishon M (2017) European Breast Cancer Conference manifesto on breast centres/units. Eur J Cancer 72:244–250. https://doi.org/10.1016/j.ejca.2016.10.023
Noguchi M, Inokuchi M, Zen Y (2009) Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy. J Surg Oncol 100(2):100–105. https://doi.org/10.1002/jso.21308
Estourgie SH, Nieweg OE, Olmos RA, Rutgers EJ, Kroon BB (2004) Lymphatic drainage patterns from the breast. Ann Surg 239(2):232–237. https://doi.org/10.1097/01.sla.0000109156.26378.90
Heuts EM, van der Ent FW, Kengen RA, van der Pol HA, Hulsewé KW, Hoofwijk AG (2006) Results of sentinel node biopsy not affected by previous excisional biopsy. Eur J Surg Oncol 32(3):278–281. https://doi.org/10.1016/j.ejso.2005.09.001
Celebioglu F, Frisell J, Danielsson R, Bergkvist L (2007) Sentinel node biopsy in non-palpable breast cancer and in patients with a previous diagnostic excision. Eur J Surg Oncol 33(3):276–280. https://doi.org/10.1016/j.ejso.2006.11.008
Luini A, Galimberti V, Gatti G, Arnone P, Vento AR, Trifirò G, Viale G, Rotmensz N, Fernandez JR, Gilardi D, Paganelli G (2005) The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat 89(2):159–163. https://doi.org/10.1007/s10549-004-1719-8
Agrawal SK, Bansawal L, Arun I, Datta SS, Chatterjee S, Ahmed R (2019) Sentinel lymph node biopsy after initial lumpectomy (SNAIL study)-a prospective validation study. Indian J Surg Oncol 10(2):350–356. https://doi.org/10.1007/s13193-018-0861-4
Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Laidley AL, McGlothin TQ, Ley PB, Brown CM, Glaser RL, Pennington RE, Turk PS, Simpson D, McMasters KM, the University of Louisville Breast Cancer Study Group (2002) The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 9(3):272–277. https://doi.org/10.1007/bf02573065
Ohtake E, Asaga T, Inaba M (2005) Sentinel lymphoscintigraphy in patients with breast cancer undergoing excisional biopsy. Ann Nucl Med 19(8):671–675. https://doi.org/10.1007/bf02985115
Arıcan P, Peksoy I, Naldöken S, Bozkurt B (2011) The effect of the excisional biopsy in the detection of the sentinel lymph node by lymphoscintigraphy and intraoperative gamma probe in breast cancer. Mol Imaging Radionucl Ther 20(3):100–103. https://doi.org/10.4274/MIRT.28
Coskun G, Dogan L, Karaman N, Ozaslan C, Atalay C (2012) Value of sentinel lymph node biopsy in breast cancer patients with previous excisional biopsy. J Breast Cancer 15(1):87–90. https://doi.org/10.4048/jbc.2012.15.1.87
Renaudeau C, Lefebvre-Lacoeuille C, Campion L, Dravet F, Descamps P, Ferron G, Houvenaeghel G, Giard S, Tunon de Lara C, Dupré PF, Fritel X, Ngô C, Verhaeghe JL, Faure C, Mezzadri M, Damey C, Classe JM (2016) Evaluation of sentinel lymph node biopsy after previous breast surgery for breast cancer: GATA study. Breast. 28:54–59. https://doi.org/10.1016/j.breast.2016.04.006
Quan ML, Wells BJ, McCready D, Wright FC, Fraser N, Gagliardi AR (2010) Beyond the false negative rate: development of quality indicators for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 17(2):579–591. https://doi.org/10.1245/s10434-009-0658-3
Acuna SA, Angarita FA, McCready DR, Escallon J (2013) Quality indicators for sentinel lymph node biopsy: is there room for improvement? Can J Surg 56(2):82–88. https://doi.org/10.1503/cjs.033011
Feldman SM, Krag DN, McNally RK, Moor BB, Weaver DL, Klein P (1999) Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 188(3):248–254. https://doi.org/10.1016/s1072-7515(98)00306-8
Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S (1998) Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186(3):275–283. https://doi.org/10.1016/s1072-7515(98)00011-8
Lyman GH, Somerfield MR, Giuliano AE (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: 2016 American Society of Clinical Oncology clinical practice guideline update summary. J Oncol Pract 13(3):196–198. https://doi.org/10.1200/JOP.2016.019992
Miner TJ, Shriver CD, Jaques DP, Maniscalco-Theberge ME, Krag DN (1999) Sentinel lymph node biopsy for breast cancer: the role of previous biopsy on patient eligibility. Am Surg 65(6):493–499
Haigh PI, Hansen NM, Qi K, Giuliano AE (2000) Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7(1):21–27. https://doi.org/10.1007/s10434-000-0021-1
Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252(3):426–433. https://doi.org/10.1097/SLA.0b013e3181f08f32
Funding
Regional Cancer Centre (RCC), Medical College Campus, Trivandrum, Kerala, India. 695011.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was cleared by institutional review board and ethics committee and is registered with Clinical Trials Registry- India (CTRI/2014/08/004920).
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Augustine, P., Dasu, S., Nair, S.P. et al. Validation of Sentinel Lymph Node Biopsy Technique Using Dual Tracer Technique in Post Lumpectomy Early Breast Cancer Patients. Indian J Surg Oncol 14, 434–439 (2023). https://doi.org/10.1007/s13193-020-01242-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-020-01242-z